5mgq: Difference between revisions

From Proteopedia
Jump to navigationJump to search
OCA (talk | contribs)
No edit summary
OCA (talk | contribs)
No edit summary
Line 1: Line 1:


==Solution structure of oxidized and amidated human IAPP (1-37), the diabetes II peptide.==
==Solution structure of oxidized and amidated human IAPP (1-37), the diabetes II peptide.==
<StructureSection load='5mgq' size='340' side='right'caption='[[5mgq]], [[NMR_Ensembles_of_Models | 20 NMR models]]' scene=''>
<StructureSection load='5mgq' size='340' side='right'caption='[[5mgq]]' scene=''>
== Structural highlights ==
== Structural highlights ==
<table><tr><td colspan='2'>[[5mgq]] is a 1 chain structure with sequence from [http://en.wikipedia.org/wiki/Human Human]. Full experimental information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5MGQ OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=5MGQ FirstGlance]. <br>
<table><tr><td colspan='2'>[[5mgq]] is a 1 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full experimental information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5MGQ OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=5MGQ FirstGlance]. <br>
</td></tr><tr id='NonStdRes'><td class="sblockLbl"><b>[[Non-Standard_Residue|NonStd Res:]]</b></td><td class="sblockDat"><scene name='pdbligand=TYC:L-TYROSINAMIDE'>TYC</scene></td></tr>
</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=TYC:L-TYROSINAMIDE'>TYC</scene></td></tr>
<tr id='gene'><td class="sblockLbl"><b>[[Gene|Gene:]]</b></td><td class="sblockDat">IAPP ([http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&srchmode=5&id=9606 HUMAN])</td></tr>
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=5mgq FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=5mgq OCA], [https://pdbe.org/5mgq PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=5mgq RCSB], [https://www.ebi.ac.uk/pdbsum/5mgq PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=5mgq ProSAT]</span></td></tr>
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=5mgq FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=5mgq OCA], [http://pdbe.org/5mgq PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=5mgq RCSB], [http://www.ebi.ac.uk/pdbsum/5mgq PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=5mgq ProSAT]</span></td></tr>
</table>
</table>
== Function ==
== Function ==
[[http://www.uniprot.org/uniprot/IAPP_HUMAN IAPP_HUMAN]] Selectively inhibits insulin-stimulated glucose utilization and glycogen deposition in muscle, while not affecting adipocyte glucose metabolism.  
[https://www.uniprot.org/uniprot/IAPP_HUMAN IAPP_HUMAN] Selectively inhibits insulin-stimulated glucose utilization and glycogen deposition in muscle, while not affecting adipocyte glucose metabolism.
<div style="background-color:#fffaf0;">
<div style="background-color:#fffaf0;">
== Publication Abstract from PubMed ==
== Publication Abstract from PubMed ==
Line 23: Line 22:
__TOC__
__TOC__
</StructureSection>
</StructureSection>
[[Category: Human]]
[[Category: Homo sapiens]]
[[Category: Large Structures]]
[[Category: Large Structures]]
[[Category: Camargo, D C.Rodriguez]]
[[Category: Reif B]]
[[Category: Reif, B]]
[[Category: Rodriguez Camargo DC]]
[[Category: Tripsianes, K]]
[[Category: Tripsianes K]]
[[Category: Protein fibril]]
[[Category: Recombinant human iapp]]
[[Category: Type ii diabetes]]

Revision as of 10:17, 14 June 2023

Solution structure of oxidized and amidated human IAPP (1-37), the diabetes II peptide.

Drag the structure with the mouse to rotate

Proteopedia Page Contributors and Editors (what is this?)

OCA